Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | USP2 | O75604 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PRKCA | P17252 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL991224 | 1.00 | MAPT (0.53) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL9717823 | 0.85 | MAPT (0.53) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL10888549 | 0.85 | MAPT (0.53) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL10886776 | 0.85 | MAPT (0.53) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL10888544 | 0.85 | MAPT (0.53) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL9717827 | 0.85 | MAPT (0.53) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL10886771 | 0.85 | MAPT (0.53) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL9617619 | 0.84 | ALDH1A1 (0.44) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL9617618 | 0.84 | ALDH1A1 (0.44) | MAPTUSP2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL16784818 | 0.84 | MAPT (0.46) | MAPTUSP2LMNACYP3A4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2003138-B1 | METHOD FOR PRODUCING ALDEHYDE USING BISPHOSPHITE AND GROUP 8-10 METAL COMPOUND, AND SUCH BISPHOSPHITE | KURARAY CO (JP) | 2013-10-09 | — | — | EP | claimed |
| US-7745666-B2 | Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; | KURARAY CO., LTD. (JP) | 2010-06-29 | — | — | US | claimed |
| US-20090259073-A1 | Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; | KURARAY CO., LTD (JP) | 2009-10-15 | — | — | US | claimed |
| EP-2003138-A1 | METHOD FOR PRODUCING ALDEHYDE USING BISPHOSPHITE AND GROUP 8-10 METAL COMPOUND, AND SUCH BISPHOSPHITE | Kuraray Co., Ltd. (JP) | 2008-12-17 | — | — | EP | claimed |
| US-5118837-A | Reaction of olefinic double bond in presence of other, less reactive olefinic double bonds; modified ruthenium catalyst with trivalent phosphorus or nitrogen or divalent sulfur compound | GIVAUDAN CORPORATION (US) | 1992-06-02 | — | — | US | claimed |
| US-4260750-A | OF DIENES, TRIARYLPHOSPHINE CATALYST | RHONE-POULENC INDUSTRIES (FR) | 1981-04-07 | — | — | US | claimed |
| US-3981907-A | Method of producing highly unsaturated compounds by reacting 1,3-conjugated diene compounds with derivatives of dimers of butadienes and products | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1976-09-21 | — | — | US | claimed |
| WO-2023167201-A1 | ACTIVE ENERGY RAY-CURABLE COMPOSITION, AND METHOD FOR PRODUCING CURED PRODUCT | 株式会社カネカ | 2023-09-07 | — | — | WO | disclosed |
| EP-4056604-B1 | METHOD FOR PRODUCING COPOLYMER OF 1,3,7-OCTATRIENE AND STYRENE | KURARAY CO (JP) | 2023-08-02 | — | — | EP | disclosed |
| EP-3564280-B1 | COPOLYMER OF 1, 3, 7-OCTATRIENE AND STYRENE AND HYDRIDE THEREOF | KURARAY CO (JP) | 2023-07-26 | — | — | EP | disclosed |
| EP-3586961-B1 | METHOD FOR MANUFACTURING CATALYST LIQUID | KURARAY CO (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-11628430-B2 | Method for manufacturing catalyst liquid | KURARAY CO., LTD. (JP) | 2023-04-18 | — | — | US | disclosed |
| EP-4163311-A1 | COPOLYMER OF 1,3,7-OCTATRIENE AND ISOPRENE, HYDRIDE THEREOF, AND METHOD FOR PRODUCING SAID COPOLYMER | Kuraray Co., Ltd. (JP) | 2023-04-12 | — | — | EP | disclosed |
| EP-0296550-A2 | Phosphonium salts and processes for production of and uses for the same | KURARAY CO., LTD. (JP) | 1988-12-28 | — | — | EP | disclosed |
| US-4399301-A | Methylenically-substituted undecadienes | RHONE-POULENC INDUSTRIES (FR) | 1983-08-16 | — | — | US | disclosed |
| US-4260750-A | OF DIENES, TRIARYLPHOSPHINE CATALYST | RHONE-POULENC INDUSTRIES (FR) | 1981-04-07 | — | — | US | disclosed |
| US-4219677-A | FOR DIENES IN PRESENCE OF SULFONATED PHOSPHINE CATALYST | RHONE-POULENC INDUSTRIES (FR) | 1980-08-26 | — | — | US | disclosed |
| US-4181683-A | INTERMEDIATES FOR PERFUMES AND ESTROGEN-DERIVATIVE DRUGS | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-4142060-A | DIENES, WATER | RHONE-POULENC INDUSTRIES (FR) | 1979-02-27 | — | — | US | disclosed |
| US-3981907-A | Method of producing highly unsaturated compounds by reacting 1,3-conjugated diene compounds with derivatives of dimers of butadienes and products | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1976-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11628430-B2 | Method for manufacturing catalyst liquid | OSGEP, PNP, ALK | MAPT 1468/4885USP2 2735/4885LMNA 1081/4885 |
| US-20090259073-A1 | Rreacting a nonconjugated diene having a double bond in an end and having from 6-20 carbon atoms with a carbon monoxide and hydrogen in the presence of a bisphosphite and a transition metal compound to provide an unsaturated acyclic aldehyde; | CBR1, RCN1, CYC1 | MAPT 4864/4885USP2 4530/4885LMNA 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.